Literature DB >> 17643258

Cytokine levels in groups of patients with different duration of chronic secretory otitis.

Svjetlana Matković1, Danilo Vojvodić, Ivan Baljosevic.   

Abstract

Chronic secretory otitis relates to the permanent presence of secretion in the middle ear for more than 3 months. The reason why applied therapy is often ineffective is that, for now, etiopathogenic molecular mechanisms responsible for the cause and the course of the secretory process in the mucus of the middle ear have not been precisely defined. Cytokines are the key mediators in middle ear inflammation with secretory otitis and regulating different inflammation states can add to the cause of the molecular processes that lead to hystopathological changes in mucus and submucus characteristically for the chronic state of secretory otitis. The aim of our work was to define the pro-inflammatory, immunoregulatory and allergy-associated cytokine levels in middle ear secretion samples of diseased children and to compare the defined values with the secretory process continuance in groups of patients who were diseased for more or less than 3 months. According to the results that have showed higher concentration of all ten examined cytokines in the secretion samples of the children who had secretory otitis for a longer time, it can be concluded that the disturbance expression regulation of the pro-inflammatory TNFalpha, TNFbeta, IL1beta, IFNgamma, IL-6 and IL-8, as well as immunoregulatory IL-2 and IL-10, and allergy associated cytokines IL-4 and IL-5 relating to the hyper production can add to the conversion of the inflammatory process to the chronic state, which has been maintained for longer than 3 months.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643258     DOI: 10.1007/s00405-007-0373-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy.

Authors:  Johan Poelmans; Jan Tack; Louw Feenstra
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-10       Impact factor: 1.547

2.  Characterization of mucins in human middle ear and Eustachian tube.

Authors:  J Lin; V Tsuprun; H Kawano; M M Paparella; Z Zhang; R Anway; S B Ho
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

3.  Role of adenoids in the pathogenesis of otitis media: a bacteriologic and immunohistochemical analysis.

Authors:  T E Linder; H P Marder; J Munzinger
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-08       Impact factor: 1.547

Review 4.  The prevalence of otitis media with effusion: a critical review of the literature.

Authors:  G A Zielhuis; G H Rach; A van den Bosch; P van den Broek
Journal:  Clin Otolaryngol Allied Sci       Date:  1990-06

5.  Role of interleukin-1beta in a murine model of otitis media with effusion.

Authors:  T Watanabe; T Hirano; M Suzuki; Y Kurono; G Mogi
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-06       Impact factor: 1.547

6.  Cytokine expression in experimental chronic otitis media with effusion in mice.

Authors:  Kazuhiko Maeda; Takashi Hirano; Issei Ichimiya; Yuichi Kurono; Masashi Suzuki; Goro Mogi
Journal:  Laryngoscope       Date:  2004-11       Impact factor: 3.325

7.  Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions.

Authors:  R F Yellon; W J Doyle; T L Whiteside; W F Diven; A R March; P Fireman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-08

8.  Interleukin-8 expression in otitis media.

Authors:  K S Maxwell; J E Fitzgerald; J A Burleson; G Leonard; R Carpenter; D L Kreutzer
Journal:  Laryngoscope       Date:  1994-08       Impact factor: 3.325

9.  Immunologic characteristics of cytokines in otitis media with effusion.

Authors:  T Himi; T Suzuki; H Kodama; H Takezawa; A Kataura
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1992-10

Review 10.  Role of allergy in eustachian tube blockage and otitis media with effusion: a review.

Authors:  J M Bernstein
Journal:  Otolaryngol Head Neck Surg       Date:  1996-04       Impact factor: 5.591

View more
  10 in total

1.  The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.

Authors:  Mohammad Faramarzi; Sareh Roosta; Mahmood Shishegar; Rohollah Abbasi; Saeid Atighechi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

2.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

3.  HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.

Authors:  Michael T Cheeseman; Hayley E Tyrer; Debbie Williams; Tertius A Hough; Paras Pathak; Maria R Romero; Helen Hilton; Sulzhan Bali; Andrew Parker; Lucie Vizor; Tom Purnell; Kate Vowell; Sara Wells; Mahmood F Bhutta; Paul K Potter; Steve D M Brown
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

4.  Characterization of mucoid and serous middle ear effusions from patients with chronic otitis media: implication of different biological mechanisms?

Authors:  Stéphanie Val; Marian Poley; Krueger Anna; Gustavo Nino; Kristy Brown; Marcos Pérez-Losada; Heather Gordish-Dressman; Diego Preciado
Journal:  Pediatr Res       Date:  2018-05-28       Impact factor: 3.756

5.  Niche- and Gender-Dependent Immune Reactions in Relation to the Microbiota Profile in Pediatric Patients with Otitis Media with Effusion.

Authors:  Frida Enoksson; Alicia Ruiz Rodriguez; Chikondi Peno; Carlos Balcazar Lopez; Fredrik Tjernström; Debby Bogaert; Anders P Hakansson; Caroline Bergenfelz
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

6.  Differentiation of otitis media-causing bacteria and biofilms via Raman spectroscopy and optical coherence tomography.

Authors:  Andrea K Locke; Farzana R Zaki; Sean T Fitzgerald; Kavya Sudhir; Guillermo L Monroy; Honggu Choi; Jungeun Won; Anita Mahadevan-Jansen; Stephen A Boppart
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

7.  Is otitis media with effusion associated with Samter's triad a new nosological entity? A preliminary report on inflammatory mediator production.

Authors:  Ljiljana Čvorović; Aleksandar Trivić; Zoran Dudvarski; Ana Jotić; Miljan Folić; Nenad Arsović; Zoran Bukumirić; Uglješa Grgurević; Danilo Vojvodić; Aleksandar Perić
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-12       Impact factor: 2.503

8.  Proteomic Characterization of Middle Ear Fluid Confirms Neutrophil Extracellular Traps as a Predominant Innate Immune Response in Chronic Otitis Media.

Authors:  Stephanie Val; Marian Poley; Kristy Brown; Rachel Choi; Stephanie Jeong; Annie Colberg-Poley; Mary C Rose; Karuna C Panchapakesan; Joe C Devaney; Marcos Perez-Losada; Diego Preciado
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

9.  Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-04-19       Impact factor: 3.372

10.  Transcript Analysis Reveals a Hypoxic Inflammatory Environment in Human Chronic Otitis Media With Effusion.

Authors:  Mahmood F Bhutta; Jane Lambie; Lindsey Hobson; Debbie Williams; Hayley E Tyrer; George Nicholson; Steve D M Brown; Helen Brown; Chiara Piccinelli; Guillaume Devailly; James Ramsden; Michael T Cheeseman
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.